387 related articles for article (PubMed ID: 25744024)
1. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
[TBL] [Abstract][Full Text] [Related]
2. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.
Krum SA; Miranda-Carboni GA; Hauschka PV; Carroll JS; Lane TF; Freedman LP; Brown M
EMBO J; 2008 Feb; 27(3):535-45. PubMed ID: 18219273
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway.
Liu W; Xu C; Zhao H; Xia P; Song R; Gu J; Liu X; Bian J; Yuan Y; Liu Z
PLoS One; 2015; 10(11):e0142519. PubMed ID: 26571489
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
[TBL] [Abstract][Full Text] [Related]
5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
6. The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis.
Kovacić N; Lukić IK; Grcević D; Katavić V; Croucher P; Marusić A
J Immunol; 2007 Mar; 178(6):3379-89. PubMed ID: 17339432
[TBL] [Abstract][Full Text] [Related]
7. Fas receptor is required for estrogen deficiency-induced bone loss in mice.
Kovacic N; Grcevic D; Katavic V; Lukic IK; Grubisic V; Mihovilovic K; Cvija H; Croucher PI; Marusic A
Lab Invest; 2010 Mar; 90(3):402-13. PubMed ID: 20084056
[TBL] [Abstract][Full Text] [Related]
8. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
Nakamura T; Imai Y; Matsumoto T; Sato S; Takeuchi K; Igarashi K; Harada Y; Azuma Y; Krust A; Yamamoto Y; Nishina H; Takeda S; Takayanagi H; Metzger D; Kanno J; Takaoka K; Martin TJ; Chambon P; Kato S
Cell; 2007 Sep; 130(5):811-23. PubMed ID: 17803905
[TBL] [Abstract][Full Text] [Related]
9. Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.
Lee J; Youn BU; Kim K; Kim JH; Lee DH; Seong S; Kim I; Han SH; Che X; Choi JY; Park YW; Kook H; Kim KK; Lim DS; Kim N
J Bone Miner Res; 2015 Sep; 30(9):1597-607. PubMed ID: 25761670
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast-osteoclast interactions.
Chen X; Wang Z; Duan N; Zhu G; Schwarz EM; Xie C
Connect Tissue Res; 2018 Mar; 59(2):99-107. PubMed ID: 28324674
[TBL] [Abstract][Full Text] [Related]
11. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
13. ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis.
Garcia AJ; Tom C; Guemes M; Polanco G; Mayorga ME; Wend K; Miranda-Carboni GA; Krum SA
J Bone Miner Res; 2013 Feb; 28(2):283-90. PubMed ID: 22927007
[TBL] [Abstract][Full Text] [Related]
14. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
[TBL] [Abstract][Full Text] [Related]
15. [Expression of Fas, FasL, and NF-kappa B in the process of osteoclast-like cell apoptosis effected by sodium fluoride].
Sun YM; Yang FJ; Li YM; Lu B; Zhu M; Qiu MC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):491-4. PubMed ID: 12905771
[TBL] [Abstract][Full Text] [Related]
16. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
17. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss.
Kleyer A; Scholtysek C; Bottesch E; Hillienhof U; Beyer C; Distler JH; Tuckermann JP; Schett G; Krönke G
J Bone Miner Res; 2012 Dec; 27(12):2442-51. PubMed ID: 22806960
[TBL] [Abstract][Full Text] [Related]
19. Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance.
Shao B; Liao L; Yu Y; Shuai Y; Su X; Jing H; Yang D; Jin Y
FASEB J; 2015 Sep; 29(9):3935-44. PubMed ID: 26062603
[TBL] [Abstract][Full Text] [Related]
20. Roles of TNF-α, GSK-3β and RANKL in the occurrence and development of diabetic osteoporosis.
Qi J; Hu KS; Yang HL
Int J Clin Exp Pathol; 2015; 8(10):11995-2004. PubMed ID: 26722385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
